Document is current
Any future updates will be listed below
-
Authors
Da Silva Cunha, Ana Lúcia
Blanter, Marfa
Renders, Janne
Gouwy, Mieke
Lorent, Natalie
Boon, Mieke
Struyf, Sofie
Carlon, Marianne S.
-
Funding
Funding for this research was provided by:
Network OrganAdvance (IDN/20/021)
BOFZAP starting grant (STG/21/064)
Fonds Wetenschappelijk Onderzoek (11B4623N)
Forton/King Baudouin (2020-J1810150-217926/1)
BOFZAP
- License Information
-
More Information
Article History
Received: 6 February 2024
Accepted: 5 December 2024
First Online: 28 December 2024
Declarations
:
: M.S.C. and M. Boon report speaker fees from Vertex Pharmaceuticals. M. Boon is member of the ERN-LUNG (European Reference Network on rare respiratory diseases) network. All other authors declare that they do not have any competing interests.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and the protocol (S57236 [ML11095]) was approved by the ethical committee of KU Leuven/UZ Leuven. Informed consent was obtained from all subjects in this study.
